Text size A A

Applied Genetic Technologies Corporation (AGTC) is a clinical stage biotechnology company dedicated to developing novel gene therapies for ophthalmic diseases. AGTC has multiple candidate gene therapeutics in or entering human clinical trials and is seeking a full-time Scientist for Early Upstream Process Development activities.

Reporting Relationship

  • The Scientist, Early Upstream Process Development will report directly to the Executive Director, Process Development

Essential Duties and Responsibilities

Job responsibilities will include, but are not limited to, the following.

  • Independently plan and execute experimental protocols
  • Cell line optimization, adaptation, screening, selection and characterization for AAV production
  • Evaluation of media formulations and process conditions on viral vector production and quality
  • Apply statistical analyses to experimental design and data sets
  • Document research with SOPs and internal reports as appropriate
  • Manage up to two Research Associates
  • Represent the company at scientific meetings and present data where applicable

Requirements

The successful candidate will meet the following requirements.

  • A Ph.D. in a biological science or engineering with 0-5 years of experience in an academic or industrial setting
  • Extensive hands-on mammalian cell culture experience in the production of biologics, preferably in both adherent and suspension formats
  • Strong molecular biological skills encompassing protein, RNA and DNA analyses by conventional and/or advanced techniques
  • Ability to identify and adapt new technologies to the production and characterization of viral vectors
  • Previous experience with viral vaccines, viruses or viral vectors is highly desired

 

AGTC offers a competitive compensation commensurate with education and experience, including salary, benefits, and company equity.  AGTC is an EOE and maintains a drug-free workplace.  Please send CV or resume to: jobs@agtc.com

Visionary science for life changing cures.